| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,579 |
10,087 |
$785K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,823 |
5,763 |
$516K |
| 99058 |
|
455 |
425 |
$29K |
| 99000 |
|
6,049 |
5,385 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
722 |
703 |
$21K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
293 |
274 |
$18K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
234 |
232 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
528 |
461 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
677 |
671 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
556 |
482 |
$5K |
| 99215 |
Prolong outpt/office vis |
42 |
42 |
$3K |
| 99205 |
Prolong outpt/office vis |
24 |
24 |
$2K |
| 87807 |
|
371 |
363 |
$2K |
| 81002 |
|
830 |
808 |
$2K |
| 92081 |
|
39 |
39 |
$390.41 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
40 |
39 |
$338.50 |
| 36415 |
Collection of venous blood by venipuncture |
29 |
29 |
$102.34 |
| 99051 |
|
5,304 |
4,975 |
$60.00 |
| 94760 |
|
5,828 |
5,398 |
$26.79 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
43 |
39 |
$26.42 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
18 |
17 |
$20.92 |